搜索
VAS2.420.76,2.81.0,,4h,24hVAS(1.050.84,0.570.76)(3.41.3,2.40.6),,,,,:1KopaczDJ,AllenHW,ThompsonGE.Acomparisonofepidurallevobupivacaine0.75%withracemicbupivacaineforlowerabdominalsurgery[J].AnesthAnalg,2000,90(3):642-648.2CasatiA,ChellyJE,CerchieriniE,etal.Clinicalproper2tiesoflevobupivacaineorracemicbupivacaineforsciaticnerveblock[J].JClinAnesth,2002,14(2):111-114.3OhmuraS,KawadaM,OhtaT,etal.Systemictoxicityandresuscitationinbupivacaine-,levobupivacaine-,orropivacaine-Infusedrats[J].AnesthAnalg,2001,93(3):743-748.4,,,.[J].,2005,24(2):119-121.5ValenzuelaC,SnydersDJ,BennettPB,etal.Stereoselec2tiveblockofcardiacsodiumchannelsbybupivacaineinguineapigventricularmyocytes[J].Circulation,1995,92(10):3014-3024.6FranquezaL,LongobardoM,VicenteJ,etal.MoleculardeterminantsofstereoselectivebupivacaineblockofhKv1.5channels[J].CircRes,1997,81(6):1053-1064.7GonzalezT,AriasC,CaballeroR,etal.Effectsoflevobupivacaine,ropivacaineandbupivacaineonHERGchannels:stereoselectivebupivacaineblock[J].BrJPharmacol,2002,137(8):1269-1279.8KawanoT,OshitaS,TakahashiA,etal.Molecularmech2anismsoftheinhibitoryeffectsofbupivacaine,levobupiva2caine,andropivacaineonsarcolemmaladenosinetriphos2phate-sensitivepotassiumchannelsinthecardiovascularsystem[J].Anesthesiology,2004,101(2):390-398.9Ala-KokkoTI,RaihaE,KarinenJ,etal.Pharmacoki2neticsof0.5%levobupivacainefollowingilioinguinal-il2iohypogastricnerveblockadeinchildren[J].ActaAnaes2thesiolScand,2005,49(3):397-400.10FosterRH,MarkhamA.Levobupivacaine:areviewofitspharmacologyanduseasalocalanaesthetic[J].Drugs,2000,59(3):551-579.11PalkamaVJ,NeuvonenPJ,OlkkolaKT.Effectofitra2conazoleonthepharmacokineticsofbupivacaineenanti2omersinhealthyvolunteers[J].BrJAnaesth,1999,83(4):659-661.12,,,.0.5%[J].,2004,24(8):582-584.13,,.[J].,2004,33(11):1045-1046.14GlaserG,MarhoferP,ZimpferG,etal.Levobupiva2caineversusracemicbupivacaineforspinalanesthesia[J].AnesthAnalg,2002,94(1):194-198.15AlleyEA,KopaczDJ,McDonaldSB,etal.Hyperbaricspinallevobupivacaine:acomparisontoracemicbupiva2caineinvolunteers[J].AnesthAnalg,2002,94(1):188-193.16SiaAT,GoyRW,LimY,etal.Acomparisonofmedi2aneffectivedosesofintrathecallevobupivacaineandropi2vacaineforlaboranalgesia[J].Anesthesiology,2005,102(3):651-656.17,,.[J].(),2004,2(4):25.18CosmoGD,MasciaA,ClementeA,etal.Useoflevobupivacaineforthetreatmentofpostoperativepainafterthoracotomies[J].MinervaAnestesiol,2005,71(6):347-351.19PapagiannopoulouP,ArgiriadoH,GeorgiouM,etal.Preincisionallocalinfiltrationoflevobupivacainevsropivacaineforpaincontrolafterlaparoscopiccholecystectomy[J].SurgEndosc,2003,17(12):1961-1964.(:2005-06-27),,,(,110016):R282:A:100422407(2006)0220094203,Ixerissonchifolia(Bge.)Hance,,,,1,20,1,,1.1,:(luteolin)-7-O--D-(luteolin-7-O--D-glucopyranoside)-7-O--D-(luteolin-7-O--D-glucuro2nopyranoside)-7-O--D-(luteolin-7-O--D-glucuronidemethylester)-7-O--D-(luteolin-7-O--D-glucuronideethylester)(apigenin)-7-O--D-(apigenin-7-O--D-glucopyranoside)-7-O--D-(apigenin-7-O--D-glucuronopyranoside)-7-O--D-(apigenin-7-O--D-glucuronidemethylester),luteolin-7-O--D-glucopyr2anosyl-(12)--D-glucopyranosideluteolin-7-O-4920064212-D-glucopyranosyl-(16)--D-glucopyranoside241.2,8-desoxyartelinixerinZ54,:A(son2chifoliactoneA)BCD41.3:(oleanicacid)(lupeol)(taraxasterylace2tate)-20--3,16--3-(Taraxaster-20-en--3,16-diol-3-acetate)4,:IxerissaponinABCD61.471.5-(-sitosterol);(E)-2,5-(E)-2,5-Dihydroxycinnamicacid;(+)-(+)-syringarensinol(scopoletin)(2-)bis-(2-Ethylhexyl)phthalate1,4-(1,4-benzenedimethanol)(p-hydroxybenzalde2hyde),22.12070,Enrlichcarcinoma22,4,,,(CTX)8,(HepG2)(SK-MEL-2)HepG2,MTT,,9,102.22080,,,,,;,,,11,(Adenosine),ADP,,;,,56,1262,,(P0.05)132.3ParkHJ,KinJY,814SohnHS430,152.4,,,112.52.5.16fMLPPMAAA,,(45kDa)32.5.2BaeSJ,,162.5.3,,172.6,LD50(44.38.1)g/kg,11,3,,;,18,,HPLC-MS,HPLC194,,,;,,,,,,,,,,,:1.()[M].:,1977.1300.2,,,.()5920064212[J].,2000,10(2):143.3LuJ,FengX,SunQ,etal.Effectofsixflavonoidcom2poundsfromIxerissonchifoliaonstimulus-inducedsuper2oxidegenerationandtyrosylphosphorylationinhumanneu2trophils[J].ClinChimActa,2002,316(1-2):95.4.[D].:.2001.6.5MaJiyuan,WangZhengtao.SesquiterpenelactonesfromIxerissonchifolia[J].Phytochemistry,1998,48(1):201.6FengXZ,DongM,GaoZJ,etal.ThreenewtriterpenoidsaponinsfromIxerissonchifoliaandtheircytotoxicactivity[J].PlantaMed,2003,69(11):1036.7,,.1.[J].,1981,12(12):4.8,.[J].,2002,23(1):79YeeSB,LeeJH,ChungHY,etal.InhibitoryeffectsofluteolinisolatedfromIxerissonchifoliaHanceontheproli2ferationofHepG2humanhepatocellularcarcinomacells[J].ArchivesofPharmacalResearch,2003,26(2):151.10SuhJ,JoY,KimND,etal.CytotoxicconstituentsoftheleavesofIxerissonchifolia[J].ArchivesofPharmacalRe2search,2003,26(3):289.11,.[J].,1979,3:31.12,,,.56[J].,1999,8(4):28-29.13,,.[J].,2001,23(4):59.14KimJai-Young,OhSe-won,KohJin-Bog.Effectsofgodulbaegipowerongrowth,proteinandlipidconcentra2tionsinrats[J].HemgukSikpumYongyangKwahakHoechi,1998,27(3):525.15SohnHeeSook.EffectsofIxerissonchifoliaHance.dietonlipidmetabolismandliverfunctionofratsadministeredwithethanol[J].HangukYongyangHankhoechi,2001,34(5):49